Back to Agenda
Session 2: Clinical Trials – From Directive to Regulation
Session Chair(s)
Nick Sykes, MS
Policy Advisor, Regulatory Strategy
EFPIA, Belgium
This session will review issues related to clinical research, for Day 1 and looking forward. This will summarise what we know, what we still don’t know and what we have to do to be prepared. UK issues vs. EU 27: IMP supply and the complex transition via Brexit and then into the new system.
Speaker(s)
Niall Dickson
NHS Confederation, United Kingdom
Chief Executive
Emma Du Four, MBA
Independent, United Kingdom
Independent Regulatory and R&D Policy Professional
Emlyn Samuel
Cancer Research UK, United Kingdom
Senior Policy Manager
Have an account?